|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-9-3
|
|
pubmed:abstractText |
Increasing attention has been focused on the use of phytotherapeutic agents to alleviate the symptoms of benign prostatic hyperplasia (BPH) in recent times. The best described and studied phytotherapeutic agent is Serenoa repens (SR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0301-1623
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
879-86
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17203353-Adrenergic alpha-1 Receptor Antagonists,
pubmed-meshheading:17203353-Adult,
pubmed-meshheading:17203353-Aged,
pubmed-meshheading:17203353-Drug Therapy, Combination,
pubmed-meshheading:17203353-Humans,
pubmed-meshheading:17203353-Male,
pubmed-meshheading:17203353-Middle Aged,
pubmed-meshheading:17203353-Phytotherapy,
pubmed-meshheading:17203353-Plant Extracts,
pubmed-meshheading:17203353-Prospective Studies,
pubmed-meshheading:17203353-Prostatic Hyperplasia,
pubmed-meshheading:17203353-Serenoa,
pubmed-meshheading:17203353-Sulfonamides,
pubmed-meshheading:17203353-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
|
|
pubmed:affiliation |
Department of Urology, Oncology Education and Research Hospital, Ankara, Turkey. fatihhizli33@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
